tiprankstipranks
Trending News
More News >
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Technical Analysis

Compare
15 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Hansa Biopharma AB’s (HNSA) Moving Averages Convergence Divergence (MACD) indicator is -1.55, suggesting Hansa Biopharma AB is a Buy.
Hansa Biopharma AB’s (HNSA) 20-Day exponential moving average is 32.11, while Hansa Biopharma AB’s (HNSA) share price is kr29.12, making it a Sell.
Hansa Biopharma AB’s (HNSA) 50-Day exponential moving average is 33.30, while Hansa Biopharma AB’s (HNSA) share price is kr29.12, making it a Sell.

Hansa Biopharma AB (HNSA) Pivot Points

Mar 15, 2026, 06:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.71
28.43
29.17
29.89
30.63
31.35
32.09
Fibonacci
28.43
28.99
29.34
29.89
30.45
30.80
31.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hansa Biopharma AB (HNSA) Moving Averages

Mar 15, 2026, 06:42 AM
Period
Simple
Exponential
MA5
29.68Sell
29.89Sell
MA10
30.87Sell
30.74Sell
MA20
32.54Sell
32.11Sell
MA50
34.26Sell
33.30Sell
MA100
32.76Sell
32.92Sell
MA200
31.23Sell
30.79Sell
Hansa Biopharma AB’s (HNSA) 10-Day exponential moving average is 30.74, while Hansa Biopharma AB’s (HNSA) share price is kr29.12, making it a Sell.
Hansa Biopharma AB’s (HNSA) 100-Day exponential moving average is 32.92, while Hansa Biopharma AB’s (HNSA) share price is kr29.12, making it a Sell.
Hansa Biopharma AB’s (HNSA) stock price is kr29.12 and Hansa Biopharma AB’s (HNSA) 50-day simple moving average is 34.26, creating a Sell signal.
Hansa Biopharma AB’s (HNSA) stock price is kr29.12 and Hansa Biopharma AB’s (HNSA) 100-day simple moving average is 32.76, creating a Sell signal.
Hansa Biopharma AB’s (HNSA) stock price is kr29.12 and Hansa Biopharma AB’s (HNSA) 200-day simple moving average is 31.23, creating a Sell signal.

Hansa Biopharma AB (HNSA) Technical Indicators

Mar 15, 2026, 06:42 AM
Name
Value
Implied Action
RSI (14)
37.14
Neutral
STOCH (9,6)
31.28
Neutral
STOCHRSI (14)
25.58
Neutral
MACD (12,26)
-1.55
Buy
ADX (14)
20.23
Neutral
Williams %R
-80.63
Buy
CCI (14)
-104.72
Buy
ATR (14)
1.96
-
Ultimate Oscillator
49.49
Neutral
ROC
-9.62
Sell
Hansa Biopharma AB’s (HNSA) Relative Strength Index (RSI) is 37.14, creating a Neutral signal.
Hansa Biopharma AB’s (HNSA) Trend Strength Indicator (ADX) is 20.23, creating a Neutral signal.
Hansa Biopharma AB’s (HNSA) Commodity Channel Index (CCI) is -104.72, creating a Buy signal.
Hansa Biopharma AB’s (HNSA) Price Rate of Change (ROC) is -9.62, creating a Sell signal.

FAQ

Is HNSA a Buy, Hold, or Sell?
Based on HNSA’s technical indicators, HNSA is a Strong Sell.
    What is HNSA’s RSI (14)?
    HNSA’s RSI (14) is 37.14, which suggests HNSA is a Neutral.
      What is HNSA’s MACD?
      HNSA’s MACD is -1.55, which suggests HNSA is a Buy.
        What is HNSA’s 5-day moving average?
        HNSA’s 5-day moving average is 29.68, which suggests HNSA is a Sell.
          What is HNSA’s 20-day moving average?
          HNSA 20-day moving average is 32.54, which suggests HNSA is a Sell.
            What is HNSA’s 50-day moving average?
            HNSA’s 50-day moving average is 34.26, which suggests HNSA is a Sell.
              What is HNSA’s 200-day moving average?
              HNSA’s 200-day moving average is 31.23, which suggests HNSA is a Sell.
                What is HNSA’s Williams % R (14)?
                HNSA’s Williams % R (14) is -80.63, which suggests HNSA is a Buy.
                  What is HNSA’s CCI (14)?
                  HNSA’s CCI (14) is -104.72, which suggests HNSA is a Buy.
                    What is the share price of Hansa Biopharma AB?